Concepedia

Udo E. W. Lange

UE

24

Publications

1.1K

Citations

16

H-Index

1970

Active since

Affiliations

BASF (Germany)(Current)

Abbott (Germany)

AbbVie (Germany)

AbbVie (United States)

Massachusetts Institute of Technology

Udo E. W. Lange is an author at BASF (Germany) specializing in pharmacology, drug discovery, and medicine.

Top concepts

PharmacologyMedicineDrug DiscoveryOrganic ChemistryChemistryPharmacotherapyMedicinal ChemistryEngineeringBiochemistryNatural Sciences

Publications per year

1970–2020

24

Publications

24

Highly Enantioselective Imine Hydrosilylation Using (<i>S,S</i>)-Ethylenebis(η<sup>5</sup>-tetrahydroindenyl)titanium Difluoride

Xavier Verdaguer, Udo E. W. Lange, Matthew T. Reding et al. · Journal of the American Chemical Society · 1996 · 268 citations

Chemical Engineering, Engineering, Titanium Difluoride +9

Amine Additives Greatly Expand the Scope of Asymmetric Hydrosilylation of Imines

Xavier Verdaguer, Udo E. W. Lange, Stephen L. Buchwald · Angewandte Chemie International Edition · 1998 · 187 citations

Chemical Engineering, Novel Organocatalysts, Engineering +12

Transcription Factor S, a Cleavage Induction Factor of the Archaeal RNA Polymerase

Winfried Hausner, Udo E. W. Lange, Meike Musfeldt · Journal of Biological Chemistry · 2000 · 92 citations · Full text

Emerging technologies for metabolite generation and structural diversification

Kevin P. Cusack, Hannes F. Koolman, Udo E. W. Lange et al. · Bioorganic & Medicinal Chemistry Letters · 2013 · 65 citations · Full text

Transcriptional fidelity and proofreading in Archaea and implications for the mechanism of TFS‐induced RNA cleavage

Udo E. W. Lange, Winfried Hausner · Molecular Microbiology · 2004 · 58 citations · Full text

Rows per page

1–5 of 24